On November 13, the Federal Trade Commission moved to block Covetrus’ proposed $3.5 billion acquisition of MWI Animal Health. For independent veterinary practices, the important part is not the courtroom drama. It is the reminder that supply purchasing is no longer just a back-office routine.
The FTC says Covetrus and MWI are the two largest suppliers in the markets for veterinary clinic distribution and distribution to large corporate accounts. The agency alleges that putting them together would reduce competition, raise costs for clinics, lower service quality, and ultimately increase prices for pet owners. Attorneys general from 13 states joined the federal complaint.
Covetrus sees it very differently. The company says the FTC is using a narrow view of the market and that practices now buy through many channels: manufacturers, regional and national distributors, online marketplaces, and direct-to-owner retail channels. Covetrus says the merger would improve efficiency, logistics, technology, and support for veterinary practices.
Both things can be true in the practical sense: practices do have more buying channels than they did years ago, and the biggest distributors still matter a great deal when a hospital needs predictable access to vaccines, pharmaceuticals, surgical supplies, white goods, rebates, terms, and in-clinic support.
Why this matters to independents
Independent practices often compete against corporate groups with central purchasing teams, dedicated analysts, and the volume to negotiate hard. The FTC’s complaint specifically notes that Covetrus and MWI serve customers ranging from single-veterinarian practices to corporate groups with hundreds of locations. That range matters.
A large group can shift purchasing across dozens or hundreds of hospitals and use that scale to push for better pricing. A two- or four-doctor independent does not have the same leverage. What independents do have is speed, discipline, and local control — if ownership treats purchasing as a strategic function rather than a monthly scramble.
The FTC also points to Vetcove and similar online tools as part of the competitive pressure between distributors, saying price comparison has helped practices use one distributor’s offer against another. Covetrus, for its part, says online veterinary marketplaces are now used by more than 60% of U.S. practices and give clinics access to dozens of distributors and thousands of manufacturers.
That is the actionable part for owners. Whether the merger is blocked, allowed, or modified, independent hospitals should not wait for the court to decide how much purchasing leverage they have.
This is not only about product price
The state and federal complaints emphasize price, but owners know the real cost of distribution includes more than the invoice line. Late shipments, backorders, inconsistent substitutions, poor rebate tracking, and weak rep support all create hidden costs.
For a small practice, one missed vaccine shipment can disrupt appointments. One poorly managed backorder can push staff into emergency substitutions, client callbacks, and doctor interruptions. A slightly cheaper unit price may not be cheaper if the vendor creates extra labor every week.
That is why this development should trigger a simple internal review. Pull your top 50 purchased items by annual spend. Identify which vendors supply them, what your real net cost is after rebates, and how often you are dealing with substitutions, delays, or support problems. Then look at your dependency risk: if one distributor changed terms next month, how much of your formulary and supply room would be affected?
A practical owner checklist
Independent practices do not need a corporate purchasing department to become more intentional. Start with five moves:
- Keep at least two active distributor relationships. Even if one is primary, the second should be real enough that your team can order quickly when needed.
- Track net cost, not just sticker price. Rebates, freight, minimums, payment terms, and staff time all belong in the comparison.
- Document service failures. Backorders, short ships, substitutions, and rep response times should be logged, not remembered vaguely.
- Review contracts before renewal. Watch for exclusivity, auto-renewal, data-sharing, rebate conditions, and minimum purchase commitments.
- Join buying or management groups thoughtfully. Group leverage can help independents, but only if the program leaves you with enough flexibility to protect patient care and margins.
The New York attorney general’s release says the companies have agreed to a temporary restraining order preventing the deal from closing before December 4, 2026. That gives the legal process some breathing room. Practice owners should use the same moment to pressure-test their own systems.
The takeaway
This lawsuit is not a final ruling on the Covetrus-MWI deal. It is, however, a clear signal that veterinary supply chains are becoming a bigger competitive battleground.
For independents, the goal is not to copy corporate purchasing. The goal is to know your numbers, preserve choice, and make sure your vendors are earning the relationship. In a market where consolidation can happen upstream as well as down the street, supply discipline is part of staying independent.
